MedPath

SIRIRAJ HOSPITAL

SIRIRAJ HOSPITAL logo
🇹🇭Thailand
Ownership
Private
Established
2012-04-26
Employees
101
Market Cap
-
Website
http://www.siphhospital.com/th/home

Clinical Trials

122

Active:4
Completed:48

Trial Phases

5 Phases

Phase 1:14
Phase 2:10
Phase 3:5
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (80 trials with phase data)• Click on a phase to view related trials

Not Applicable
44 (55.0%)
Phase 1
14 (17.5%)
Phase 2
10 (12.5%)
Phase 4
7 (8.8%)
Phase 3
5 (6.3%)

Malnutrition Prevalence and Nutritional Change After Preoperative Nutrition Counseling

Recruiting
Conditions
Nutrition Status
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
Siriraj Hospital
Target Recruit Count
600
Registration Number
NCT07125859
Locations
🇹🇭

Faculty of Medicine Siriraj Hospital, Bangkok, Thailand

The Pilot Study of the Utilization of Suggested Immobilization Test (SIT) for Diagnostic Confirmation of Restless Leg Syndrome in Thai Population

Not Applicable
Not yet recruiting
Conditions
Restless Leg Syndrome
First Posted Date
2025-08-08
Last Posted Date
2025-08-08
Lead Sponsor
Siriraj Hospital
Target Recruit Count
30
Registration Number
NCT07110961

The Role of Angiographic Measurements and Anatomical Correlations in Intra-Aortic Balloon Pump (IABP) Size Selection

Recruiting
Conditions
Intra-aortic Balloon Pump
First Posted Date
2025-04-27
Last Posted Date
2025-04-27
Lead Sponsor
Siriraj Hospital
Target Recruit Count
68
Registration Number
NCT06947174
Locations
🇹🇭

Siriraj Hospital, Bangkok Noi, Bangkok, Thailand

Budesonide Irrigation in Allergic Rhinitis

Phase 4
Not yet recruiting
Conditions
Allergic Rhinitis
Interventions
Drug: The budesonide nasal irrigation
Drug: The budesonide nasal spray
First Posted Date
2025-01-21
Last Posted Date
2025-01-21
Lead Sponsor
Siriraj Hospital
Target Recruit Count
78
Registration Number
NCT06785662
Locations
🇹🇭

Siriraj Hospital, Mahidol University, Bangkok, Thailand

Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients with Aspirin Resistance

Phase 3
Recruiting
Conditions
Myeloproliferative Neoplasms (MPN)
Interventions
Drug: 81-mg aspirin once daily
Drug: 81-mg aspirin twice daily
First Posted Date
2024-12-18
Last Posted Date
2024-12-27
Lead Sponsor
Siriraj Hospital
Target Recruit Count
240
Registration Number
NCT06740916
Locations
🇹🇭

Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Bangkok Noi, Bangkok, Thailand

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.